Dr Lal Pathlabs Ltd Share Price
(LALPATHLAB)
₹2559.8▲1.09%
as on 04:01PM, 19 Mar 2025
Dr Lal Pathlabs Ltd Performance
Day's Low
Day's High
₹2,521.05Day's Price Range₹2,579.9552 Week's Low
52 Week's High
₹1,943.752-Week Price Range₹3,653.95
| Returns % | |
| 1 Month Return | -3.09 % |
| 3 Month Return | -16.22 % |
| 1 Year Return | + 25.91 % |
| Market Stats | |
| Previous Close | ₹2,532.20 |
| Open | ₹2,521.05 |
| Volume | 1.37L |
| Upper Circuit | ₹3,038.60 |
| Lower Circuit | ₹2,025.80 |
| Market Cap | ₹21,167.10Cr |
Dr Lal Pathlabs Ltd Fundamentals
P/E Ratio
50.6
PEG Ratio
4.9
Market Cap
₹21,167.10 Cr
P/B Ratio
9.94
EPS
43.4
Dividend Yield
0.8
Sector
Healthcare
ROE
21.42
Mutual Fund Holdings of Dr Lal Pathlabs Ltd
Dr Lal Pathlabs Ltd Analyst Rating
based on 23 analysts
60.87%
Buy
8.70%
Hold
30.43%
Sell
Based on 23 analysts offering long term price targets for Dr Lal Pathlabs Ltd. An average target of ₹3121.74
Source: S&P Global Market Intelligence
Dr Lal Pathlabs Ltd Share analysis
Dr Lal Pathlabs Ltd price forecast by 23 analysts
Upside of23.28%
High
₹3770
Target
₹3121.74
Low
₹2380
Dr Lal Pathlabs Ltd target price ₹3121.74, a slight upside of 23.28% compared to current price of ₹2559.8. According to 23 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Dr Lal Pathlabs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:38.77%
Forecast
Actual
Including amortisation and stock based compensations
Dr Lal Pathlabs Ltd EPS growth forecast
EPS estimate Q1, FY2027:62.10%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Dr Lal Pathlabs Ltd
Dr. Lal PathLabs Consolidates Operations with Subsidiary Liquidation - 19 Mar, 2025
Dr. Lal PathLabs has announced the voluntary liquidation of its subsidiary, Suburban Diagnostics, effective March 18, 2025. This consolidation aims to streamline operations and enhance market positioning, as Suburban contributed significantly to the company's turnover and net worth in the last financial year.HDFC Securities Sets Target Price for Dr Lal Pathlabs - 18 Mar, 2025
HDFC Securities has an 'add' call on Dr Lal Pathlabs with a target price of Rs 2,910, reflecting a 10% discount to its long-term PE average. The company reported a consolidated total income of Rs 621.80 crore for Q4 FY24, down 8.84% from the previous quarter but up 11.59% year-on-year. Promoters hold 53.91% stake, while FIIs and DIIs own 26.82% and 12.87%, respectively.
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 9.84% to 10.25% in Dec 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, LALPATHLAB stock has moved up by 25.9%
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 201.1% return, outperforming this stock by 206.0%
- NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 26.82% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 53.8% return, outperforming this stock by 27.9%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 53.92% to 53.91% in Dec 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 129.2 Cr → 96.7 Cr (in ₹), with an average decrease of 25.2% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 6.04% to 5.82% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 682.1 Cr → 621.8 Cr (in ₹), with an average decrease of 8.8% per quarter
Dr Lal Pathlabs Ltd Financials
Dr Lal Pathlabs Ltd Index Inclusions
Dr Lal Pathlabs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.91% | ||
| Foreign Institutions | 26.82% | ||
| Mutual Funds | 10.25% | 4.14 | |
| Retail Investors | 5.82% | ||
| Others | 3.21% |
Dr Lal Pathlabs Ltd Key Indicators
Dr Lal Pathlabs Ltd Valuation
Dr Lal Pathlabs Ltd in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (50.60x)
March 18, 2025
Industry (92.83x)
March 18, 2025
Highest (95.62x)
November 5, 2020
Dr Lal Pathlabs Ltd Earnings and Dividends
Dr Lal Pathlabs Ltd Earnings Results
Dr Lal Pathlabs Ltd’s net profit jumped 18.94% since last year same period to ₹96.70Cr in the Q3 2024-2025. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated -25.15% fall in its net profits since last 3-months.
Read More about Earnings ResultsDr Lal Pathlabs Ltd Dividends January,2025
In the quarter ending December 2024, Dr Lal Pathlabs Ltd has declared dividend of ₹6 - translating a dividend yield of 1.41%.
Read More about Dividends
Dr Lal Pathlabs Ltd Technicals Summary
Bearish
Neutral
Bullish
Dr Lal Pathlabs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Dr Lal Pathlabs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹21,167.10 Cr | 17.46% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹31,662.21 Cr | 146.61% | 0.67 | ₹168 Cr | ₹5,040 Cr | |
| HOLD | ₹57,517.94 Cr | 24.18% | 0.56 | ₹1,811 Cr | ₹12,667 Cr | |
| BUY | ₹11,143.73 Cr | 15.02% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹3,893.96 Cr | 9.69% | 0.54 | ₹69 Cr | ₹571 Cr |
About Dr Lal Pathlabs Ltd
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Revenue: ₹596.70Cr as on December 2024 (Q4 24)
Net Profit: ₹98.10Cr as on December 2024 (Q4 24)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
FAQs on Dr Lal Pathlabs Ltd
What is Dr Lal Pathlabs Ltd price today?
Dr Lal Pathlabs Ltd share price today stands at ₹2559.8, Open: ₹2521.05, Previous Close: ₹2532.2, High: ₹2579.95, Low: ₹2521.05, 52 Week High: ₹3653.95, 52 Week Low: ₹1943.7.
How to Buy Dr Lal Pathlabs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Dr Lal Pathlabs Ltd shares
What are today's traded volumes of Dr Lal Pathlabs Ltd?
Today's traded volume of Dr Lal Pathlabs Ltd(LALPATHLAB) is 1.37L.
What is today's market capitalisation of Dr Lal Pathlabs Ltd?
Today's market capitalisation of Dr Lal Pathlabs Ltd(LALPATHLAB) is ₹21167.1Cr.
What is the 52 Week High and Low Range of Dr Lal Pathlabs Ltd?
How much percentage Dr Lal Pathlabs Ltd is down from its 52 Week High?
Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2559.8. It is down -29.94% from its 52 Week High price of ₹3653.95
How much percentage Dr Lal Pathlabs Ltd is up from its 52 Week low?
Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2559.8. It is up 31.70% from its 52 Week Low price of ₹1943.7